Optimising cell culture conditions, Shimadzu release the C2MAP-2000, which not only carries out all steps from pretreatment to measurement without any human intervention, but also shortens culture media analysis by 80%
The new C2MAP automated pretreatment module covers all steps from pretreatment to measurement without any human intervention. This highly efficient system can even be run by less experienced operators
Celebrating 50 years in Europe, Shimadzu releases the new C2MAP-2000 automated pretreatment module for cell culture media analysis. The C2MAP-2000 can be used to pretreat culture media samples by adding reagents such as a deproteinising agent or internal standard substance, filter precipitated proteins and dilute samples.
The C2MAP system combines the C2MAP-2000 module with a Shimadzu ultra-fast liquid chromatograph mass spectrometer (LC-MS/MS). By automating all the process steps from pretreatment to measurement, the C2MAP system shortens the culture media analysis time for up to 95 components in culture supernatants to one sixth of the previous level.1 In addition, this system can be operated by less experienced operators.
After loading culture supernatant samples, reagents and pairs of filter and recovery vials, the C2MAP-2000 module is able to execute all steps from pretreatment to LC-MS/MS measurement without any human intervention. This seamless execution not only makes it easy to process samples unattended overnight or on non-working days, but also enables samples to be controlled using the same ID for all process steps. This minimises risk of selecting the wrong sample while ensuring traceability. C2MAP-TRENDS time course viewer software loads the measurement data obtained and graphs temporal changes in each component concentration as trend graphs.
For the antibody pharmaceutical market it has become increasingly important to record the consumption of components and accumulation of waste matter (secreted metabolites) in culture media, so that cell cultivation parameters can be optimised for manufacturing drug substances. In addition, for regenerative medicine fields involving iPS, ES or other cells, there is a need for technology that can evaluate cell quality in real time without damaging the cells. Furthermore, there is also a need to reduce the replacement frequency of expensive culture media. Since monitoring the changes in culture supernatant components over time provides information that is useful in these fields, the role of LC-MS/MS analysis has increased the optimisation of cell culture conditions.
However, due to a lack of products available for seamlessly performing of all processes from sample preparation to measurement, there was a need for a system that could be used easily, even by less experienced operators. Shimadzu therefore developed the C2MAP-2000 automated pretreatment module and the C2MAP system for steps involved in determining the status of cultures and researching cultivation process steps at major pharmaceutical companies, biotech ventures, pharmaceutical CMOs (contract manufacturing organisations) and various research institutions. In the future, Shimadzu intends to offer solutions based on LC-MS/MS measurement technology for controlling and optimising of cell cultivation process steps.
C2MAP-2000 automated pretreatment module:
Nexera X2 ultra high performance liquid chromatograph:
LCMS-8060/8050 ultra-fast liquid chromatograph mass spectrometer:
C2MAP TRENDS special viewer software: